Angiodynamics, Inc. (ANGO) Tops Q3 EPS by 1c; Guides Q4, FY12
Tweet
Share
E-mailGet Alerts ANGO Hot Sheet
Price: $15.75 --0%
Financial Fact:
Total operating expenses: 41.46M
Today's EPS Names:
NSLR, OCTV, ACB, More
Financial Fact:
Total operating expenses: 41.46M
Today's EPS Names:
NSLR, OCTV, ACB, More
Join SI Premium – FREE
Angiodynamics, Inc. (NASDAQ: ANGO) reported Q3 EPS of $0.09, $0.01 better than the analyst estimate of $0.08. Revenue for the quarter came in at $51.6 million versus the consensus estimate of $51.34 million.
Angiodynamics, Inc. sees FY2012 EPS of $0.42-$0.44, versus the consensus of $0.39. Angiodynamics, Inc. sees FY2012 revenue of $216.2-$218.2 million, versus the consensus of $216.5 million.
Angiodynamics, Inc. sees Q4 2012 EPS of $0.09-$0.11, versus the consensus of $0.10. Angiodynamics, Inc. sees Q4 2012 revenue of $52.1-$54.1 million, versus the consensus of $53.08 million.
For earnings history and earnings-related data on Angiodynamics, Inc. (ANGO) click here.
Angiodynamics, Inc. sees FY2012 EPS of $0.42-$0.44, versus the consensus of $0.39. Angiodynamics, Inc. sees FY2012 revenue of $216.2-$218.2 million, versus the consensus of $216.5 million.
Angiodynamics, Inc. sees Q4 2012 EPS of $0.09-$0.11, versus the consensus of $0.10. Angiodynamics, Inc. sees Q4 2012 revenue of $52.1-$54.1 million, versus the consensus of $53.08 million.
For earnings history and earnings-related data on Angiodynamics, Inc. (ANGO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stran & Company, Inc. (SWAG) Reports Q2 EPS of $0.02
- Canterbury Park (CPHC) Misses Q2 EPS by 3c
- Erasca, Inc. (ERAS) Misses Q2 EPS by 3c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
